The 71 rating InvestorsObserver gives to Soleno Therapeutics Inc (SLNO) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 83 percent of stocks in the Biotechnology industry, SLNO’s 71 overall rating means the stock scores better than 71 percent of all stocks.
SLNO has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on SLNO!